Treatment of polyendocrine metabolic ovarian syndrome in the glucagon-like peptide-1 era

Initially approved for the treatment of type 2 diabetes mellitus, glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1

Cumulative probability of a live birth after up to six sequential single euploid embryo transfers

To estimate the cumulative probability of achieving at least one live birth (LB) after up to six sequential single euploid embryo transfers (euploid SET) and characterize per-transfer outcomes to

Endocrine disease and pregnancy loss—a nationwide cohort study

To investigate associations between endocrine diseases and pregnancy loss, including associations according to the number of pregnancy losses, temporal patterns, and familial clustering

Artificial intelligence-based embryo ranking can match or improve traditional assessments but cannot predict an aneuploid chromosomal constitution

To evaluate whether artificial intelligence (AI)-based blastocyst ranking tools can outperform traditional noninvasive assessments in prioritizing euploid embryos for transfer.

How early-life adversity relates to reproductive health: fertility and pregnancy outcomes in the Norwegian HUNT Study

To provide a more comprehensive understanding of how childhood adversity influences reproductive trajectories, this study assessed associations between childhood adversities and parity,

Uterine applications of the laparoscopic ultrasound

To demonstrate the use and setup of a laparoscopic ultrasound (LUS), and show its application during a myomectomy.

The Blastocyst Era: Is Blastocyst Transfer the Best Strategy for Every Patient?

Reflections on the journey to renaming polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome

We have together spent more than 100 years researching and caring for those with a condition that affects one in eight women globally: a condition whose name has been inaccurate and misleading. A

More than cycles: rethinking cancer surveillance in polyendocrine metabolic ovarian syndrome

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS) is a common condition affecting up to 20% of the population. The condition is characterized by

From fetal life to adulthood: cardiometabolic health of offspring conceived by assisted reproductive technologies, a systematic review

The number of children conceived through assisted reproductive technologies (ART) continues to increase worldwide, raising questions regarding their long-term cardiometabolic health. Both ART